NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - ImageneBio, Inc. - 1.01 / 3.02 / 9.01
Filed:
2026-04-13
AccNo:
0001193125-26-151942
Size:
693 KB
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits
发布时间04/13 11:10 UTC
首次发现04/13 11:11 UTC
热度106.9
重要度80
情绪-0.08
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 707 字符
Form 8-K - Current report: SEC Accession No. 0001193125-26-151942
Filing Date: 2026-04-13
Accepted: 2026-04-13 07:10:07
Documents: 14
Period of Report: 2026-04-12
Items: Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
ImageneBio, Inc. (Filer) CIK : 0001835579 (see all company filings) EIN. : 811697316 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | 8-K | d143873d8k.htm iXBRL | 8-K
2 | EX-4.1 | d143873dex41.htm | EX-4.1
3 | EX-4.2 | d143873dex42.htm | EX-4.2
4 | EX-10.1 | d143873dex101.htm | EX-10.1